HEALTH OF WOMAN.2015.1(97):79-82; doi 10.15574/HW.2015.97.79 
 

Diagnosis of neurohormonal mechanisms of regulation of blood circulation as a cause of heart failure in pregnant women with pulmonary hypertension and congenital heart disease and blood vessels 
 

Davydova Y. V., Limanskaya A. Y., Lukyanov I. S., Ogorodnik A. A.

SІ Іnstitute of pediatrics, obstetrics and gynecology of NAMS of Ukraine 
 

The article shows the research, the main purpose of which is to assess the prognostic value of basic and follow-BNP levels in pregnant women with pulmonary hypertension and congenital heart disease, depending on the clinical and echocardiographic parameters. Defined that BNP is an early marker, reliable screening test for the diagnosis of heart failure in patients with insignificant symptoms, reflects the value of the individual cardiovascular risk, determines the prognosis of the disease and can be used for the selection and monitoring the effectiveness of the therapy. 
 

Key words: pregnancy, heart failure, pulmonary hypertension, congenital heart disease, BNP. 
 

REFERENCES

1. Carvalho J. 2000. Cardiovascular disease in the pregnant patient, Textbook of Obstetric Anesthesia. Edited by Birnbach DJ, Gatt SP, Datta S. Philadelphia, Churchill Livingstone: 553–64.

2. Cheek TG, Gutsche BB. 2001. Maternal physiologic alteration during pregnancy, Shnider and Levinson’s Anesthesia for Obstetrics. Edited by Hugues SC, Levinson G, Rosen MA. Philadelphia, Lippincott Williams & Wilkins: 3–18.

3. Diller G.P., Dimopoulos K., Okonko D., Li W., Babu-Narayan S.V., et al. 2005. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 112:828–83. http://dx.doi.org/10.1161/CIRCULATIONAHA.104.529800; PMid:16061735

4. Fisher C., Berry C., Blue L., Morton J.J., McMurray J. N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart200389879881

5. Hameed A.B., Chan K., Ghamsary M., Elkayam U. Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum. //Clin Cardiol. 2009 Aug;32(8):E60-2. doi: 10.1002/clc.20391. http://dx.doi.org/10.1002/clc.20391

6. Khairy P., Ionescu-Ittu R., Mackie A.S., Abrahamowicz M., Pilote L., Marelli A.J. 2010. Changing mortality in congenital heart disease.// J Am Coll Cardiol. 56:1149–1157. http://dx.doi.org/10.1016/j.jacc.2010.03.085; PMid:20863956

7. Rasiah S.V., Publicover M., Ewer A.K., Khan K.S., Kilby M.D., Zamora J. 2006. Systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol. 28:110–116. http://dx.doi.org/10.1002/uog.2803; PMid:16795132

8. Regitz-Zagrosek V., Gohlke-Barwolf C., Geibel-Zehender A., Haas W., Kruck I., Nienaber C. 2008. Heart diseases in pregnancy. Clin Res Cardiol. 97:630–665. http://dx.doi.org/10.1007/s00392-008-0685-2; PMid:18574542

9. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr. Rev.200324341356.